Free
Retraction  |   October 2005
AQUAVAN® Injection, a Water-soluble Prodrug of Propofol, as a Bolus Injection: A Phase I Dose-escalation Comparison with DIPRIVAN® (Part 2): Pharmacodynamics and Safety: Retracted
Author Affiliations & Notes
  • Michel M. R. F. Struys, M.D., Ph.D.
    *
  • Ann L. G. Vanluchene, M.D.
  • Ekaterina Gibiansky, Ph.D.
  • Leonid Gibiansky, Ph.D.
    §
  • James Vornov, M.D., Ph.D.
  • Eric P. Mortier, M.D., D.Sc.
    #
  • Luc Van Bortel, M.D., Ph.D.
    **
  • * Professor in Anesthesia and Research Coordinator, † Staff Anesthesiologist, # Professor in Anesthesia and Chair, Department of Anesthesia, Ghent University Hospital. ‡ Head, Pharmacometrics, and Principal Scientist, ∥ Director, Clinical Research, Guilford Pharmaceuticals Inc., Baltimore, Maryland. § Former position: Senior Statistician, Emmes Corporation, Rockville, Maryland. Current position: Principal Scientist, Metrum Research Group, Avon, Connecticut. ** Professor, Clinical Pharmacology and Pharmacotherapy, Heymans Institute of Pharmacology, Ghent University, and Head of Drug Research Unit Ghent, Ghent University Hospital.
Article Information
Retraction
Retraction   |   October 2005
AQUAVAN® Injection, a Water-soluble Prodrug of Propofol, as a Bolus Injection: A Phase I Dose-escalation Comparison with DIPRIVAN® (Part 2): Pharmacodynamics and Safety: Retracted
Anesthesiology 10 2005, Vol.103, 730-743. doi:
Anesthesiology 10 2005, Vol.103, 730-743. doi:
First Page Preview
First page PDF preview
First page PDF preview ×
View Large